116 related articles for article (PubMed ID: 870161)
1. Direct leukocyte migration inhibition by myelin basic protein in exacerbations of multiple sclerosis.
Sheremata W; Triller H; Cosgrove JB; Eylar EH
Can Med Assoc J; 1977 May; 116(9):985-8. PubMed ID: 870161
[TBL] [Abstract][Full Text] [Related]
2. [Leukocyte migration inhibition test in multiple sclerosis - results of a migration technic according to Clausen using brain specific antigens].
Lehmitz R; Meyer-Rienecker HJ; Werner H; Eichler R
Psychiatr Neurol Med Psychol (Leipz); 1980 Oct; 32(10):577-87. PubMed ID: 6164068
[TBL] [Abstract][Full Text] [Related]
3. Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.
Sheremata W; Sazant A; Watters G
Can Med Assoc J; 1978 Mar; 118(5):509-13. PubMed ID: 343902
[TBL] [Abstract][Full Text] [Related]
4. Effect of encephalitogenic protein on migration in agarose of leukocytes from patients with multiple sclerosis. A longitudinal study of patients with relapsing multiple sclerosis or with cerebral infarction.
Källén B; Nilsson O; Thelin C
Acta Neurol Scand; 1977 Jan; 55(1):47-56. PubMed ID: 65098
[TBL] [Abstract][Full Text] [Related]
5. In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases.
Lisak RP; Zweiman B
N Engl J Med; 1977 Oct; 297(16):850-3. PubMed ID: 904660
[TBL] [Abstract][Full Text] [Related]
6. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte migration inhibition by myelin basic protein.
Brandes LJ
Can Med Assoc J; 1977 Sep; 117(6):577. PubMed ID: 902202
[No Abstract] [Full Text] [Related]
8. Effect of encephalitogenic protein on migration in agarose of leukoytes from patients with multiple sclerosis. A longitudinal study of patients with relapsing multiple sclerosis or with cerebral infarction.
Källen B; Nilsson O; Thelin C
Acta Neurol Scand; 1977 Jan; 55(1):47-56. PubMed ID: 65894
[TBL] [Abstract][Full Text] [Related]
9. Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.
Kateley JR; Bazzell SJ
Clin Exp Immunol; 1979 Feb; 35(2):218-26. PubMed ID: 312171
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immunity to measles, myelin basic protein, and central nervous system extract in multiple sclerosis. A longitudinal study employing direct buffy coat migration inhibition assays.
Lisak RP; Zweiman B; Waters D; Korpowski H; Pleasure DE
Neurology; 1978 Aug; 28(8):798-803. PubMed ID: 567297
[TBL] [Abstract][Full Text] [Related]
11. Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis.
Sheremata W; Cosgrove JB; Eylar EH
N Engl J Med; 1974 Jul; 291(1):14-7. PubMed ID: 4598923
[No Abstract] [Full Text] [Related]
12. Retrobulbar neuritis. In vitro evidence of sensitization to myelin basic protein in patients without multiple sclerosis.
Sheremata W; Younge B; Eylar EH
Neurology; 1977 Jun; 27(6):557-60. PubMed ID: 559264
[TBL] [Abstract][Full Text] [Related]
13. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis.
Olsson T; Baig S; Höjeberg B; Link H
Ann Neurol; 1990 Feb; 27(2):132-6. PubMed ID: 1690527
[TBL] [Abstract][Full Text] [Related]
14. Cellular hypersensitivity in attacks of multiple sclerosis. I. A comparative study of migration inhibitory factor production and lymphoblastic transformation in response to myelin basic protein in multiple sclerosis.
Colby SP; Sheremata W; Bain B; Eylar EH
Neurology; 1977 Feb; 27(2):132-9. PubMed ID: 556829
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis: sensitization of a myelin basic protein fragment (peptide T) encephalitogenic to primates. A preliminary report.
Sheremata W; Eylar EH; Cosgrove JB
J Neurol Sci; 1977 Jun; 32(2):255-63. PubMed ID: 69018
[TBL] [Abstract][Full Text] [Related]
16. Cellular hypersensitivity in Guillain-Barré syndrome.
Sheremata WA; Rocklin RE; David J
Can Med Assoc J; 1974 Jun; 110(11):1245-7. PubMed ID: 4366128
[TBL] [Abstract][Full Text] [Related]
17. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.
Sun J; Link H; Olsson T; Xiao BG; Andersson G; Ekre HP; Linington C; Diener P
J Immunol; 1991 Mar; 146(5):1490-5. PubMed ID: 1899688
[TBL] [Abstract][Full Text] [Related]
18. [Determination of a factor inhibiting migration of leukocytes to brain antigens, its concentration in serum and spontaneous leukocyte migration in multiple sclerosis].
Loĭko TP; Ierusalimskiĭ AP; Lozovoĭ VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):187-90. PubMed ID: 3518311
[TBL] [Abstract][Full Text] [Related]
19. Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis.
Hafler DA; Benjamin DS; Burks J; Weiner HL
J Immunol; 1987 Jul; 139(1):68-72. PubMed ID: 2438352
[TBL] [Abstract][Full Text] [Related]
20. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
Martin R; Voskuhl R; Flerlage M; McFarlin DE; McFarland HF
Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
